Icon

VYVANSE (nda021977)- (10MG,20MG,30MG,40MG,50MG,60MG,70MG)

LISDEXAMFETAMINE DIMESYLATE TAKEDA PHARMS USA
10MG,20MG,30MG,40MG,50MG,60MG,70MG
Yes No
2023-Aug-24 2012-Feb-23
None None
None No
VYVANSE is a central nervous system (CNS) stimulant indicated for the treatment of: • Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older • Moderate to severe binge eating disorder (BED) in adults
13 1 10
Total Other Developers 2
Drugs with Suitability No
10MG ** ** Up - 7
20MG ** ** Up - 9
30MG ** ** Up - 10
40MG ** ** Up - 10
50MG ** ** Up - 10
60MG ** ** Up - 10
70MG ** ** Up - 10
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** ************** *** *********** ** ***** ********* **, ********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ******** ********, *** *********** **** ******** ******, ************, ************ (**) *****, ****** ****** (***) ***
****** ******** *** ******** ***** ** *** */*/* ******** ************ *********** **** ******** ****., *********, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** *** ***** **** *** *** ************ ***. *********** ** ******** ****, *** *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** *** ****** *** *********** *** ******** ****** *.*. *** *, ******, *** **** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** *************** *.*. *********** **** ************* **** *, ******, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ****** ****** *************** ** *** ****, *** *********** ** ***** ***, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******* ******* ***************, ***. *********** **** ***** ******* **, *******, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.